Cognitive and symptomatic predictors of functional disability in schizophrenia.
about
The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy peopleHospitalization and psychosis: influences on the course of cognition and everyday functioning in people with schizophreniaCriterion and construct validity of the CogState Schizophrenia Battery in Japanese patients with schizophreniaVocational rehabilitation for adults with psychotic disorders in a Scandinavian welfare societyNegative affect predicts social functioning across schizophrenia and bipolar disorder: Findings from an integrated data analysis.Revisiting the therapeutic effect of rTMS on negative symptoms in schizophrenia: a meta-analysis.Investigational drugs for schizophrenia targeting the dopamine receptor: phase II trials.Nicotine dependence in the mental disorders, relationship with clinical indicators, and the meaning for the user.Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia.One-year randomized controlled trial and follow-up of integrated neurocognitive therapy for schizophrenia outpatients.The MATRICS Consensus Cognitive Battery (MCCB): clinical and cognitive correlates.Prediction of functional outcome in individuals at clinical high risk for psychosisAssessing cognitive function in bipolar disorder: challenges and recommendations for clinical trial design.Psychosocial functioning in schizophrenia: are some symptoms or demographic characteristics predictors across the functioning domains?Correlations between physical activity and neurocognitive domain functions in patients with schizophrenia: a cross-sectional studyEmotion awareness and regulation in individuals with schizophrenia: Implications for social functioning.Neuropsychological profile in adult schizophrenia measured with the CMINDSDo people with schizophrenia lack emotional intelligence?Empirical evidence for discrete neurocognitive subgroups in bipolar disorder: clinical implicationsDissecting psychiatric spectrum disorders by generative embedding.Assessing long-term test-retest reliability of the CPT-IP in schizophrenia.Genes and schizophrenia: from a Festschrift Seminar honoring William T. Carpenter Jr, MD.From perception to functional outcome in schizophrenia: modeling the role of ability and motivation.Neurocognition: clinical and functional outcomes in schizophrenia.Deficits in visual working-memory capacity and general cognition in African Americans with psychosis.Schizophrenia and work: aspects related to job acquisition in a follow-up study.Effort discounting and its association with negative symptoms in schizophrenia.Targeting neuronal dysfunction in schizophrenia with nicotine: Evidence from neurophysiology to neuroimaging.Beyond the GWAS in schizophrenia.Beyond dopamine: glutamate as a target for future antipsychotics.Dysfunction of Cognition Patterns Measured by MATRICS Consensus Cognitive Battery (MCCB) among First Episode Schizophrenia Patients and Their Biological Parents.Symptom severity is more closely associated with social functioning status in inpatients with schizophrenia than cognitive deficitsThe importance of measuring psychosocial functioning in schizophrenia.Influence of antipsychotic treatment type and regimen on the functionality of patients with schizophrenia.Factors associated with occupational and academic status in patients with first-episode psychosis with a particular focus on neurocognition.Impaired verbal learning in forensic inpatients with Schizophrenia Spectrum Disorder.Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives.Comparison of self-report and performance-based measures of everyday functioning in individuals with schizophrenia: implications for measure selection.Occupational functioning, symptoms and neurocognition in patients with psychotic disorders: investigating subgroups based on social security status.Social cognition in patients with schizophrenia spectrum and bipolar disorders with and without psychotic features.
P2860
Q26799352-17336D67-3A26-471E-8D68-F736CBA01D47Q26995247-76D6F0A1-590E-492D-BDD5-66F69322E7DEQ28744227-84755EE4-0543-4AEE-8F8C-2A99C744215CQ30835191-A5C36A1E-D4E5-421E-B4A5-2661BD171104Q31114703-B93407B8-4C93-4762-8D3C-AE81EF85B1B3Q34022882-F2DFAADB-0051-4598-A127-7C5CF9567411Q34703195-90B321EE-230E-4E5B-B724-1C3F98FFBF04Q34935349-8398D068-2362-4F7C-ADD5-B54449626DE7Q35100117-8484D641-F197-4CC2-8DE8-BBE803CEA15FQ35369948-DE5CC001-87E9-4E65-A174-7EF658BC40A3Q35633150-664C2340-ACAA-4173-8C24-14E0302C3F73Q35747146-C0F9057C-13B2-4D2E-BCF6-E095F2A5B124Q35755808-3BE3A83F-4EA7-4943-8145-28AD84D46BC9Q36140353-5E894BBB-F07A-4DAE-8EE2-8BE98F16C2A8Q36241093-434EC57F-8EFA-4C7E-8198-01D9920361CFQ36312936-490F1A57-0BA9-4CE5-A0E7-464FD9395245Q36408176-D5C53EF4-A4A6-40F9-B0A2-4EE51618C357Q36490569-B174B6BA-7D4C-4040-B6C4-AAFA9B772425Q36702358-9559E122-A9A5-4C9B-A314-16B5EEEB5C82Q37393835-5B397727-F366-46AE-A3C0-3E912788AAA9Q37452816-D3A2FF03-2012-4091-8D43-7625C773DF84Q37602618-68434E8D-DD0E-4309-92DC-B3020857510CQ37687029-33ABD1D1-1751-4FEC-9C89-8986B674BDB5Q38180211-CF87FE1A-9321-473C-BEBC-D74444002F11Q38607220-6AAB9D7E-12EE-4E8F-938B-966C967E3ACAQ38612509-B412489E-C7B4-471C-B5DF-1046655F8298Q39064413-81FD6A6E-C314-4873-B0CD-A942402F5D3BQ39261867-3529B6C6-61DC-40C7-B7A6-51D552899CAAQ39548316-C432181A-106A-4232-ACDE-9EADEA0F2E87Q39580232-0FA77D37-3137-4B06-AFA7-279557159188Q41582912-5EEAE416-A03F-4A39-B5DF-6B41BD82424EQ41904208-E428BFA6-3E56-454B-9C78-2F5D0E3E9656Q42791247-F944A925-D96A-43B9-A035-4BB5C2AAEC20Q45362751-5ED9D11F-B5C3-4DA8-A726-7C5D80C73A53Q45390199-3FD1B813-CE8A-4448-9043-AC2072B3B4FFQ46015345-AA29C34C-81E5-4F77-8FAC-A93DF69A8013Q46162601-32E51BFC-F1CF-4AA7-922D-59C99DCE8B45Q46295062-23BB5860-A638-4774-A940-5B716EE7FDE2Q46433147-6F107548-64FA-47D4-ABF6-8B5B8990E9E1Q47550674-6E2821DB-75E2-4F50-A8F6-122577C0C878
P2860
Cognitive and symptomatic predictors of functional disability in schizophrenia.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cognitive and symptomatic predictors of functional disability in schizophrenia.
@ast
Cognitive and symptomatic predictors of functional disability in schizophrenia.
@en
Cognitive and symptomatic predictors of functional disability in schizophrenia.
@nl
type
label
Cognitive and symptomatic predictors of functional disability in schizophrenia.
@ast
Cognitive and symptomatic predictors of functional disability in schizophrenia.
@en
Cognitive and symptomatic predictors of functional disability in schizophrenia.
@nl
prefLabel
Cognitive and symptomatic predictors of functional disability in schizophrenia.
@ast
Cognitive and symptomatic predictors of functional disability in schizophrenia.
@en
Cognitive and symptomatic predictors of functional disability in schizophrenia.
@nl
P2093
P2860
P1476
Cognitive and symptomatic predictors of functional disability in schizophrenia.
@en
P2093
Anil K Malhotra
Jean-Pierre Lindenmayer
Katherine E Burdick
Pamela DeRosse
Ron Brenner
Syed Shamsi
P2860
P304
P356
10.1016/J.SCHRES.2010.08.007
P407
P50
P577
2010-09-15T00:00:00Z